CN1157390C - 吲哚衍生物 - Google Patents

吲哚衍生物 Download PDF

Info

Publication number
CN1157390C
CN1157390C CNB011034440A CN01103444A CN1157390C CN 1157390 C CN1157390 C CN 1157390C CN B011034440 A CNB011034440 A CN B011034440A CN 01103444 A CN01103444 A CN 01103444A CN 1157390 C CN1157390 C CN 1157390C
Authority
CN
China
Prior art keywords
indol
palladium
ylmethyl
reaction
triazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB011034440A
Other languages
English (en)
Chinese (zh)
Other versions
CN1322725A (zh
Inventor
Cy
C·Y·陈
�������ɭ
R·D·拉森
���˹���Ѷ���
T·R·费尔霍文
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of CN1322725A publication Critical patent/CN1322725A/zh
Application granted granted Critical
Publication of CN1157390C publication Critical patent/CN1157390C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Inorganic Insulating Materials (AREA)
CNB011034440A 1994-05-24 1995-05-19 吲哚衍生物 Expired - Lifetime CN1157390C (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/248,288 US5567824A (en) 1994-05-24 1994-05-24 Palladium catalyzed ring closure of triazolyltryptamine
US248288 1994-05-24
US248,288 1994-05-24

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN95194106A Division CN1077104C (zh) 1994-05-24 1995-05-19 钯催化的三唑基色胺闭环反应

Publications (2)

Publication Number Publication Date
CN1322725A CN1322725A (zh) 2001-11-21
CN1157390C true CN1157390C (zh) 2004-07-14

Family

ID=22938473

Family Applications (2)

Application Number Title Priority Date Filing Date
CNB011034440A Expired - Lifetime CN1157390C (zh) 1994-05-24 1995-05-19 吲哚衍生物
CN95194106A Expired - Lifetime CN1077104C (zh) 1994-05-24 1995-05-19 钯催化的三唑基色胺闭环反应

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN95194106A Expired - Lifetime CN1077104C (zh) 1994-05-24 1995-05-19 钯催化的三唑基色胺闭环反应

Country Status (24)

Country Link
US (1) US5567824A (https=)
EP (1) EP0763032B1 (https=)
JP (1) JP3947216B2 (https=)
KR (1) KR100385027B1 (https=)
CN (2) CN1157390C (https=)
AT (1) ATE252095T1 (https=)
AU (1) AU688505B2 (https=)
DE (1) DE69531939T2 (https=)
DK (1) DK0763032T3 (https=)
ES (1) ES2207648T3 (https=)
FI (1) FI116899B (https=)
HK (1) HK1041262B (https=)
HR (1) HRP950304B1 (https=)
HU (1) HU226460B1 (https=)
MX (1) MX9605838A (https=)
NZ (1) NZ285539A (https=)
PT (1) PT763032E (https=)
RO (1) RO118586B1 (https=)
RU (1) RU2138496C1 (https=)
SK (1) SK284495B6 (https=)
TW (1) TW300221B (https=)
UA (1) UA52586C2 (https=)
WO (1) WO1995032197A1 (https=)
YU (1) YU49345B (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA965837B (en) * 1995-07-11 1997-01-31 Merck & Co Inc A triazolylmethyl-indole ethylamine bisulfate salt
ATE207485T1 (de) * 1995-07-11 2001-11-15 Merck & Co Inc Ein triazolylmethyl-indol-ethylamin-bisulfat-salz
US5808064A (en) * 1996-08-13 1998-09-15 Merck & Co., Inc. Palladium catalyzed indolization
US5877329A (en) * 1996-08-13 1999-03-02 Merck & Co., Inc. Palladium catalyzed indolization
US5811551A (en) * 1996-08-13 1998-09-22 Merck & Co., Inc. Palladium catalyzed indolization
WO1998006725A1 (en) * 1996-08-13 1998-02-19 Merck & Co., Inc. Palladium catalyzed indolization
ES2215670T3 (es) * 1999-06-28 2004-10-16 Janssen Pharmaceutica N.V. Inhibidores de la replicacion del virus sincitial respiratorio.
ES2204303B2 (es) * 2002-08-07 2004-12-16 Laboratorios Vita, S.A. Procedimiento para la obtencion de un compuesto farmaceuticamente activo.
EP1709032A2 (en) 2004-01-09 2006-10-11 Ratiopharm GmbH Crystalline forms of rizatriptan benzoate
US7786156B2 (en) 2004-01-28 2010-08-31 Ratiopharm Gmbh Synthesis methods and intermediates for the manufacture of Rizatriptan
GT200500065A (es) * 2004-03-26 2005-10-24 Procedimientos para la preparacion de compuestos aminoarilos yodados
WO2006082598A2 (en) * 2005-02-01 2006-08-10 Natco Pharma Limited Novel crystalline forms of rizatriptan benzoate
WO2006137083A1 (en) * 2005-06-20 2006-12-28 Natco Pharma Limited Improved process for the preparation of rizatriptan benzoate
WO2007054979A1 (en) * 2005-11-14 2007-05-18 Matrix Laboratories Ltd Process for the large scale production of rizatriptan benzoate
ATE510836T1 (de) * 2006-01-19 2011-06-15 Matrix Lab Ltd Umwandlung eines aromatischen diazoniumsalzes in ein arylhydrazin
AU2008259518A1 (en) * 2007-06-04 2008-12-11 Generics [Uk] Limited Novel process
WO2017130141A1 (en) 2016-01-27 2017-08-03 Instar Technologies A.S. Oromucosal nanofiber carriers for therapeutic treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ283018B6 (cs) * 1991-02-01 1997-12-17 Merck Sharp And Dohme Limited Deriváty imidazolu, triazolu a tetrazolu a farmaceutické přípravky na jejich bázi
CA2084531A1 (en) * 1991-12-19 1993-06-20 David W. Smith Antimigraine 4-pyrimidinyl and pyridinyl derivatives of indol-3yl-alkyl piperazines
GB9215526D0 (en) * 1992-07-22 1992-09-02 Merck Sharp & Dohme Chemical process

Also Published As

Publication number Publication date
HK1041262B (zh) 2005-04-15
HU226460B1 (en) 2008-12-29
NZ285539A (en) 1998-06-26
WO1995032197A1 (en) 1995-11-30
HUT76469A (en) 1997-09-29
HU9603236D0 (en) 1997-01-28
HRP950304B1 (en) 2004-12-31
DE69531939D1 (de) 2003-11-20
FI964669L (fi) 1996-11-22
AU688505B2 (en) 1998-03-12
TW300221B (https=) 1997-03-11
CN1077104C (zh) 2002-01-02
FI964669A0 (fi) 1996-11-22
HK1041262A1 (en) 2002-07-05
PT763032E (pt) 2004-02-27
YU33495A (sh) 1998-07-10
KR970703336A (ko) 1997-07-03
ES2207648T3 (es) 2004-06-01
CN1152920A (zh) 1997-06-25
MX9605838A (es) 1997-12-31
AU2467195A (en) 1995-12-18
DE69531939T2 (de) 2004-07-29
CN1322725A (zh) 2001-11-21
JP3947216B2 (ja) 2007-07-18
US5567824A (en) 1996-10-22
KR100385027B1 (ko) 2003-08-14
SK284495B6 (sk) 2005-05-05
DK0763032T3 (da) 2004-02-09
RU2138496C1 (ru) 1999-09-27
UA52586C2 (uk) 2003-01-15
HRP950304A2 (en) 1997-08-31
HK1009045A1 (en) 1999-05-21
JPH10500680A (ja) 1998-01-20
EP0763032B1 (en) 2003-10-15
SK149896A3 (en) 1997-09-10
EP0763032A1 (en) 1997-03-19
YU49345B (sh) 2005-07-19
RO118586B1 (ro) 2003-07-30
ATE252095T1 (de) 2003-11-15
FI116899B (fi) 2006-03-31

Similar Documents

Publication Publication Date Title
CN1157390C (zh) 吲哚衍生物
CN1053190C (zh) 新的喹喔啉二酮衍生物、其制备方法和作为药物的应用
CN1137103C (zh) 制备三唑啉硫酮衍生物的方法
CN85104233A (zh) 化学化合物
CN101044138A (zh) 吲唑化合物的制备方法
CN1203589A (zh) 新的化合物
CN1178924C (zh) 制备三唑啉硫酮衍生物的方法
CN100349892C (zh) 抗菌的吲哚酮唑烷酮、它们的制备中间体和含有它们的药物组合物
CN1083430C (zh) 咔唑酮衍生物
CN1671669A (zh) 二芳基吡唑的合成方法
CN1070403A (zh) 新的-β-咔啉衍生物及其制备和药物应用
CN1918168A (zh) 制备3－o－保护吗啡酮和3－o－保护吗啡酮二烯醇羧酸酯的方法
CN1162303A (zh) 制备烷氧基亚氨基乙酰胺衍生物的方法
CN1922193A (zh) 化学方法
CN1112113A (zh) 新的三唑化合物及其制备方法和用途
CN1620425A (zh) 制备氨基甲酸2－(取代苯基)－2－羟基－乙酯的方法
CN1400976A (zh) 吲哚吡咯并咔唑衍生物的制备方法、制备中的中间体以及制备中间体的方法
CZ296249B6 (cs) Zpusob výroby triazolyltryptaminového derivátu
HK1009045B (en) Palladium catalyzed ring closure of triazolyl tryptamine
HK1032588A (en) Method for producing triazolinthion derivatives
CN1580058A (zh) 3－氯甲基－3－头孢烯衍生物结晶的制造方法
HK1032592A (en) Method for producing triazolinthion derivatives
HK1032587A (en) Method for producing triazolinethione derivatives
HK1015674A1 (en) Benzimidazole compounds and their use as modulators of the gaba(a) receptor complex

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1041262

Country of ref document: HK

C56 Change in the name or address of the patentee

Owner name: MERCK & CO. INC.

Free format text: FORMER NAME OR ADDRESS: MERCK + CO., INC.

CP01 Change in the name or title of a patent holder

Address after: New jersey, USA

Patentee after: MERCK & Co.,Inc.

Address before: New jersey, USA

Patentee before: MERCK & Co.,Inc.

C56 Change in the name or address of the patentee

Owner name: MERCK + CO INC

Free format text: FORMER NAME: MERCK + CO

CP01 Change in the name or title of a patent holder

Address after: New jersey, USA

Patentee after: MERCK SHARP & DOHME Corp.

Address before: New jersey, USA

Patentee before: MERCK & Co.,Inc.

ASS Succession or assignment of patent right

Owner name: SCHERING CORP (US)

Free format text: FORMER OWNER: MSD CORP.

Effective date: 20121025

C41 Transfer of patent application or patent right or utility model
C56 Change in the name or address of the patentee

Owner name: MSD CORP.

Free format text: FORMER NAME: SCHERING CORP (US)

CP01 Change in the name or title of a patent holder

Address after: New jersey, USA

Patentee after: MERCK SHARP & DOHME Corp.

Address before: New jersey, USA

Patentee before: SCHERING Corp.

TR01 Transfer of patent right

Effective date of registration: 20121025

Address after: New jersey, USA

Patentee after: SCHERING Corp.

Address before: New jersey, USA

Patentee before: MERCK SHARP & DOHME Corp.

C17 Cessation of patent right
CX01 Expiry of patent term

Expiration termination date: 20150519

Granted publication date: 20040714